The 2016-2021 Outlook for Systemic Broad- And Medium-Spectrum Antibiotic Erythromycins in Japan
This focused reference presents an outlook for systemic broad- and medium-spectrum antibiotic erythromycins in Japan during 2016–2021. It provides a concise resource for pharmaceutical researchers, healthcare industry professionals, and readers seeking market-oriented information about this specific antibiotic category.
About This Book
This publication examines systemic broad- and medium-spectrum antibiotic erythromycins in Japan.
It focuses on the 2016–2021 outlook period.
The subject matter is relevant to readers researching pharmaceutical products, antibiotic markets, and developments in Japan.
Prepared by Icon Group International, this concise reference is intended for focused market and industry research.
Reviews
No reviews yet. Be the first to review this book!